FdaApplication
ANDA 220972
Identifiers
- fda_app_no: ANDA220972
Properties
| Property | Value |
|---|---|
| applicant_name | SCIEGEN PHARMACEUTICALS INC |
| application_type | ANDA |
| approval_date | 2026-06-25 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TOFACITINIB CITRATE | TOFACITINIB CITRATE | EQ 22MG BASE | TABLET, EXTENDED RELEASE;ORAL |
| TOFACITINIB CITRATE | TOFACITINIB CITRATE | EQ 11MG BASE | TABLET, EXTENDED RELEASE;ORAL |
2 products